Metformin upregulates atrogin-1 in MI/R myocardium by activating AMPK and by enhancing the interaction between atrogin-1 and CHMP2B to degrade CHMP2B and, thereby, protecting autophagy. The gene discussed is FBXO32; the disease is myocardial infarction.